Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Failure of allopurinol to provide clinically significant protection against the hematologic toxicity of a bolus 5-FU schedule
H. Garewal
, F. R. Ahmann
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Failure of allopurinol to provide clinically significant protection against the hematologic toxicity of a bolus 5-FU schedule'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
5-fluorouracil (5-FU)
100%
Adult Patients
11%
Allopurinol
100%
Bolus
100%
Bolus Injection
22%
Clinically Significant
100%
Consecutive Days
11%
Dose Escalation
11%
Gastrointestinal Toxicity
11%
Gram-negative Sepsis
11%
Hematotoxicity
100%
In(III)
11%
Leukopenia
11%
Metastatic Malignancy
11%
Myelosuppression
11%
Myelotoxicity
11%
Neurotoxicity
11%
Thrombocytopenia
11%
Pharmacology, Toxicology and Pharmaceutical Science
Allopurinol
100%
Bone Marrow Suppression
11%
Bone Marrow Toxicity
11%
Fluorouracil
100%
Gastrointestinal Toxicity
11%
Gram Negative Sepsis
11%
Leukopenia
11%
Neurotoxicity
11%
Thrombocytopenia
11%